PT  - JOURNAL ARTICLE
AU  - Sean O'Donnell
TI  - Proceedings of 2019 Viral Clearance Symposium: Introduction
AID  - 10.5731/pdajpst.2021.012676
DP  - 2021 Jan 01
TA  - PDA Journal of Pharmaceutical Science and Technology
PG  - pdajpst.2021.012676
4099  - http://journal.pda.org/content/early/2021/12/15/pdajpst.2021.012676.short
4100  - http://journal.pda.org/content/early/2021/12/15/pdajpst.2021.012676.full
AB  - ABSTRACT: This article introduces the presentations from the 2019 Viral Clearance Symposia which was held in Claremont, California. The Viral Clearance Symposia contained regulatory perspectives presented by representative from the Paul -Ehrlich-Institute, FDA and Health Canada. Industry members presented on several areas related to viral safety including viral clearance strategies for manufacturing processes, continuous processing, upstream and facility risk mitigation, virus detection methods and continuous processing.